EQS Newswire is a major provider of regulatory and corporate news. It mainly serves companies, investors and media worldwide. Through its services, EQS Newswire enables efficient and secure communication between companies and their stakeholders. Its main services include the distribution of ad hoc announcements, corporate news and the publication of financial reports that meet strict international standards.
Tue, 05.11.2024
Trostberg, November 5, 2024 – The Management Board of Alzchem Group AG has resolved, with the approval of the Supervisory Board, to buy back up to 100.000 shares in the company via the stock exchange for a total purchase price of up to EUR 6 million (excluding transaction costs) over a period of up to 12 months from December 2024.
The buyback is f...
Provision of balancing energy: Alzchem Group AG supports grid stability through flexible load control
Trostberg, October 24, 2024 – Alzchem Group AG, a globally active specialty chemicals company, makes a significant contribution to the stability of the power grid with its two carbide furnaces at the Hart site. The electrical output of both furnac...
Alzchem Group AG plans to double nitroguanidine production capacity in Germany
Trostberg, October 2, 2024 – Alzchem Group AG, a vertically integrated specialty chemicals supplier with a leading market position in selected niche markets, plans to significantly increase its production capacity for nitroguanidine. It was only in spring of this year t...
Trostberg, October 2, 2024 – Alzchem Group AG plans significantly increase its production capacity for nitroguanidine. It was only in spring of this year that the company announced a capacity expansion for the preliminary stage with an investment of EUR 76 million over several years. Taking into account the additional expansion plans for a new prod...
Alzchem Group AG set to join the SDAX on October 2, 2024
Trostberg, October 1, 2024 – Alzchem Group AG, a vertically integrated specialty chemicals supplier with a leading market position in selected niche markets, will be included in the SDAX selection index for the first time on October 2, 2024. This makes Alzchem one of the 160 largest and most...
Alzchem Group AG: Continued strong growth in Specialty Chemicals business leads to significant EBITDA increase of 41.2% to EUR 51.9 million in the first half of 2024
Half-year result climbs by 78.4% to EUR 26.7 million
Free cash flow increases by 64.5% to EUR 51.4 million
Management Board raises earnings forecasts for the full year 2024
Trostbe...
Alzchem Group AG raises forecasts for EBITDA and EBITDA margin in fiscal year 2024
Trostberg, July 30, 2024 – Alzchem Group AG is raising its earnings forecasts for fiscal year 2024. Group EBITDA will grow to over EUR 100 million with unchanged sales expectations (original forecast: approx. EUR 90 million). The raise in the EBITDA forecast leads t...
Alzchem Group AG: Three Alzchem climate projects receive public funding of around EUR 850 thousand
Trostberg, June 7, 2024 – Alzchem has received funding commitments totaling around EUR 850 thousand, which represent non-repayable investment grants this year. Alzchem Group AG, a vertically integrated specialty chemicals supplier with a leading mark...
Alzchem Group AG receives strong support from shareholders at Annual General Meeting; dividend increase to EUR 1.20 per share approved
Trostberg, May 7, 2024 – At today’s virtual Annual General Meeting, the Management Board and Supervisory Board once again received strong approval from the shareholders of Alzchem Group AG for their direction of th...
Alzchem Group AG receives strong support from shareholders at Annual General Meeting; dividend increase to EUR 1.20 per share approved
Trostberg, May 7, 2024 – At today’s virtual Annual General Meeting, the Management Board and Supervisory Board once again received strong approval from the shareholders of Alzchem Group AG for their direction of th...
You have pressed the "". We would like to inform you that you are now leaving the information service of the portal site ayondo.com. You will be redirected to . After confirming the "Continue" button, you confirm that you have been informed of this. You also confirm that you are carrying out this process of your own free will and that it is not the result of any promotional activity or other influence. Continue to .